Cross-suppression of EGFR ligands amphiregulin and epiregulin and de-repression of FGFR3 signalling contribute to cetuximab resistance in wild-type KRAS tumour cells

por Oliveras-Ferraros, C, Cufí, S, Queralt, B, Vazquez-Martin, A, Martin-Castillo, B, de Llorens, R, Bosch-Barrera, J, Brunet, J, Menendez, J A
Publicado 2012

SEOM clinical guidelines for the treatment of malignant pleural mesothelioma (2020)

por Nadal, E., Bosch-Barrera, J., Cedrés, S., Coves, J., García-Campelo, R., Guirado, M., López-Castro, R., Ortega, A. L., Vicente, D., de Castro-Carpeño, J.
Publicado 2021

Metronomic oral vinorelbine in previously untreated advanced non-small-cell lung cancer patients unfit for platinum-based chemotherapy: results of the randomized phase II Tempo Lun...

por Camerini, A., Morabito, A., Montanino, A., Bernabé, R., Grossi, F., Ramlau, R., Ciuleanu, T.-E., Ceresoli, G.-L., Pasello, G., de Marinis, F., Bosch-Barrera, J., Laundreau, P., Gautier, S., Ta Thanh Minh, C., Kowalski, D.
Publicado 2021

Identifying and preventing burnout in young oncologists, an overwhelming challenge in the COVID-19 era: a study of the Spanish Society of Medical Oncology (SEOM)

por Jiménez-Labaig, P., Pacheco-Barcia, V., Cebrià, A., Gálvez, F., Obispo, B., Páez, D., Quílez, A., Quintanar, T., Ramchandani, A., Remon, J., Rogado, J., Sánchez, D.A., Sánchez-Cánovas, M., Sanz-García, E., Sesma, A., Tarazona, N., Cotés, A., González, E., Bosch-Barrera, J., Fernández, A., Felip, E., Vera, R., Rodríguez-Lescure, Á., Élez, E.
Publicado 2021